ARTELO (ARTL) Director Robert E. Martin Receives 136-Share Award

What Happened

• Robert E. Martin, a director of ARTELO BIOSCIENCES, was granted a derivative award for 136 shares on July 17, 2026. The award was reported as acquired at $0.00 (no cash paid). This is an equity award (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: July 17, 2026; Filing date: July 21, 2026 (filed on time).
• Price: $0.00 per share; total reported value: $0.
• Shares reported acquired: 136 derivative shares.
• Shares owned after transaction: Not reported in this Form 4.
• Vesting footnote: 100% of the shares vest on the earlier of (i) one year after the Vesting Commencement Date or (ii) the day before the issuer’s next annual meeting. Vesting Commencement Date is July 17, 2026.
• No indication of tax withholding, 10b5-1 plan, or immediate sale in the filing.

Context

• This is a time-based equity award tied to continued service (common for directors and employees). Such grants are routine compensation and are not a direct market signal like a purchase or sale. Because the award vests only after meeting the service condition, the shares are not immediately available for sale.